Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate.
Gorospe M, Shack S, Guyton KZ, Samid D, Holbrook NJ. Gorospe M, et al. Among authors: samid d. Cell Growth Differ. 1996 Dec;7(12):1609-15. Cell Growth Differ. 1996. PMID: 8959328
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.
DiGiuseppe JA, Weng LJ, Yu KH, Fu S, Kastan MB, Samid D, Gore SD. DiGiuseppe JA, et al. Among authors: samid d. Leukemia. 1999 Aug;13(8):1243-53. doi: 10.1038/sj.leu.2401471. Leukemia. 1999. PMID: 10450753 Free article.
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Samid D, Shack S, Myers CE. Samid D, et al. J Clin Invest. 1993 May;91(5):2288-95. doi: 10.1172/JCI116457. J Clin Invest. 1993. PMID: 8486788 Free PMC article.
Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.
Liu L, Shack S, Stetler-Stevenson WG, Hudgins WR, Samid D. Liu L, et al. Among authors: samid d. J Invest Dermatol. 1994 Sep;103(3):335-40. doi: 10.1111/1523-1747.ep12394874. J Invest Dermatol. 1994. PMID: 8077698
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.
Liu L, Hudgins WR, Miller AC, Chen LC, Samid D. Liu L, et al. Among authors: samid d. Cytokine. 1995 Jul;7(5):449-56. doi: 10.1006/cyto.1995.0061. Cytokine. 1995. PMID: 7578983
Increased susceptibility of ras-transformed cells to phenylacetate is associated with inhibition of p21ras isoprenylation and phenotypic reversion.
Shack S, Chen LC, Miller AC, Danesi R, Samid D. Shack S, et al. Among authors: samid d. Int J Cancer. 1995 Sep 27;63(1):124-9. doi: 10.1002/ijc.2910630122. Int J Cancer. 1995. PMID: 7558439
Cytostatic activity of phenylacetate and derivatives against tumor cells. Correlation with lipophilicity and inhibition of protein prenylation.
Hudgins WR, Shack S, Myers CE, Samid D. Hudgins WR, et al. Among authors: samid d. Biochem Pharmacol. 1995 Oct 12;50(8):1273-9. doi: 10.1016/0006-2952(95)02013-3. Biochem Pharmacol. 1995. PMID: 7488244
Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D, Srikantan V, Wilson VL, Bassin RH, Samid D. Rimoldi D, et al. Among authors: samid d. Cancer Res. 1991 Jan 1;51(1):324-30. Cancer Res. 1991. PMID: 1703037
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE. Thibault A, et al. Among authors: samid d. Clin Cancer Res. 1996 Mar;2(3):483-91. Clin Cancer Res. 1996. PMID: 9816194 Clinical Trial.
Phenylacetate is an inhibitor of prostatic growth and development in organ culture.
Lipschutz JH, Samid D, Cunha GR. Lipschutz JH, et al. Among authors: samid d. J Urol. 1996 May;155(5):1762-70. J Urol. 1996. PMID: 8627880
69 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page